Summary: Quantitative receptor autoradiography was used to evaluate the density of high-affinity binding sites for the "peripheral-type" benzodiazepine receptor (PTBR) ligand [3H]PK11195 in brain regions of the rat at different stages of pyrithiamine-induced thiamine defi ciency encephalopathy, an experimental model of the Wernicke-Korsakoff syndrome (WKS). Assessment of the density of [3H]PK11195 binding sites in thiamine deficient animals showing no neurologic signs of thiamine deficiency encephalopathy, and revealed no significant alterations compared with pair-fed control animals in any brain region studied. Densities of [3H]PK 11195 binding sites were, however, significantly increased in brain re gions of the rat at the symptomatic stage, where increased densities were seen in the inferior colliculus (233% in crease, p < 0.001), inferior olivary nucleus (154% in crease, p < 0.001) and thalamus (up to 107% increase, p Thiamine, in the form of thiamine pyrophos phate, is a cofactor for several enzymes involved in cerebral glucose metabolism, including the pyru vate dehydrogenase (a-KGDH) complex, the a-ke toglutarate dehydrogenase complex, and transketo lase (TK), which are important for energy produc tion and synthesis of neurotransmitters such as glutamate, ,),-aminobutyric acid, and aspartate. Py rithiamine-induced thiamine deficiency in the rat re sults in region-selective metabolic abnormalities in-
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cluding reduced activities of a-KGDH (Butterworth et aI., 1986) and increased concentrations of brain lactate (Hakim, 1984) and alanine (Butterworth and Heroux, 1989) . Metabolic perturbations are partic ularly evident in brain regions such as the thalamus, a region that ultimately manifests neuronal cell loss in this model of thiamine deficiency encephalopathy (Troncoso et aI., 1981; Aikawa et aI., 1984) . The nature and distribution of the brain lesions in py rithiamine-treated rats closely resembles those re ported in the Wernicke-Korsakoff syndrome (WKS) in humans.
"Peripheral-type" benzodiazepine receptors (PTBRs) are highly localized on nonneuronal cells, particularly on the outer membrane of mitochondria in astrocytes (Syapin and Skolnick, 1979; McCarthy and Harden, 1981; Tardy et aI., 1981; Hertz, 1985, 1987; Anholt et aI., 1986; Basile and Skolnick, 1986) . Densities of PTBRs have been shown to be increased in membrane preparations from rat striata following intrastriatal injection of excitotoxic compounds (Schoemaker et aI., 1982; Owen et aI., 1983; Benavides et aI., 1987) , as well as in postmortem brain tissue from patients with Hun tington's disease (Schoemaker et aI., 1982) and Alz heimer's disease (Owen et aI., 1983; D'Iorio et aI., 1991) . The increases in densities of PTBRs follow ing excitotoxic lesions were found to be mirrored by decreases in activities of the neuronal marker en zymes choline acetyltransferase and glutamic acid decarboxylase (Benavides et aI. , 1987) , and by his tologic evidence of neuronal loss and increased gli osis (Schoemaker et aI., 1982) . Because glial prolif eration, following neuronal degeneration, could be responsible for the increase in PTBRs, it has been suggested that levels of PTBRs can be used as an indirect index of neuronal damage (Benavides et aI., 1987) .
Experimental thiamine deficiency is character ized by pathologic lesions, symmetric in distribu tion, and found selectively in brain regions includ ing the thalamus, mammillary bodies, inferior olive, and inferior colliculi (Troncoso et aI., 1981) . Recent evidence suggests that glutamate-induced excito toxicity may play a key role in the pathogenesis of neuronal cell death in thiamine deficiency (Langlais and Mair, 1990) . As part of a series of investigations of the pathophysiologic mechanisms implicated in thiamine deficiency encephalopathy, quantitative receptor autoradiography was used to measure the densities of eH]PK11195 binding sites in vulnerable and nonvulnerable brain regions of the rat at differ ent stages of thiamine deficiency encephalopathy.
MATERIALS AND METHODS

Treatment groups
Male Sprague-Dawley rats weighing 175-200 g were used for the experiments described. All animals were housed individually in the Andre-Viallet Clinical Re search Centre's animal quarters under constant condi tions of temperature, humidity, and light cycles. The fol lowing treatment groups were used for the studies de scribed.
Group 1: pair-fed controls. Rats were fed a thiamine deficient diet (ICN, Nutritional Biochemicals, Cleveland, OH, U.S.A.) pair-fed to equal food consumption to that of rats in Groups 2 and 3. In addition, all rats received thiamine subcutaneously in a dosage of 10 tLg 100 g body weight-I day-I.
Group 2: PT presymptomatic. Rats were fed a thia mine-deficient diet and administered pyrithiamine subcu taneously (50 tLg in 0.2 ml of saline 100 g body weighC I day-I) for 7 days. At this time rats showed no evidence of neurologic abnormalities (normal gait, normal righting reflexes).
Group 3: PT symptomatic. Rats were fed a thiamine deficient diet and administered pyrithiamine subcutane ously (50 tLg in 0.2 ml of saline 100 g body weight-I day-I). Neurologic status was evaluated daily (Butter worth and Heroux, 1989 ) until loss of righting reflex was evident; this stage was generally between days 12 and 14.
Quantitative receptor autoradiography
Rats were decapitated and the brains removed rapidly and frozen in isopentane chilled on dry ice. Frozen brains were mounted onto microtome chucks. Brain sections (20 tLm thick) were cut using a microtome cryostat at -18°C and were thaw-mounted onto gelatin-coated glass micro scope slides. Brain sections were kept at -70°C before use in binding experiments.
For binding experiments brain sections were incubated for 60 min at 25°C in Tris-HCl buffer (170 mM, pH 7.4) containing 1 nM [3H]PKI1195 (specific activity 86 Ci/mmol, New England Nuclear). Nonspecific binding was defined by incubating adjacent sections in the pres ence of 10 tLM PKI1195. The incubation was terminated by rinsing sections three times for 5 min in ice-cold incu bation buffer. Sections were then dipped briefly in cold distilled water and dried rapidly under a stream of cold air.
Autoradiograms were prepared by apposing sections together with tissue-calibrated standards of known 3H_ concentrations (Amersham microscales) to 3H-sensitive Hyperfilm (Amersham) for 4 weeks. Films were devel oped and tissue concentrations of [3H]PKII195 were measured by quantitative densitometry analysis using a MCID computer-based densitometer and image analysis system (Imaging Research, Ontario, Canada). The amount of [3H]PK11195 bound to various brain regions was calculated from the specific activity of the ligand. Specific binding in each area was calculated by subtract ing from the total binding the amount bound in corre sponding regions in adjacent sections incubated for non specific labeling.
Histologic analysis
Sections adjacent to those used for autoradiography were stained with cresyl violet using standard histologic techniques and then viewed by light microscopy. Neuro nal cell counts were made by a neuropathologist (L.O.) who was blinded to the treatment group. Measurements were made within fields measuring 500 x 500 tLm, in sec tions observed at 250x magnification.
Statistical analysis
Data are presented as mean ± SD. Statistical compar isons of binding site densities and neuronal cell counts between pair-fed control and pyrithiamine-treated groups were performed with the two-tailed Student's t test.
RESULTS
In agreement with previous reports (Gibson et aI., 1984; Butterworth and Heroux, 1989) , daily ad ministration of pyrithiamine to rats on a thiamine deficient diet resulted, within 14 days, in neurologic signs of thiamine deficiency such as loss of righting reflex. Pair-fed control animals showed no such neurologic symptoms. Measurement of thiamine status using the erythrocyte TK assay revealed sig-nificant thiamine deficiency in pyrithiamine-treated animals in all cases (data not shown).
Autoradiographic studies
Assessment of the density of eH]PKI 1 195 bind ing sites in pre symptomatic pyrithiamine-treated animals revealed no significant differences between treated animals and pair-fed control animals (Ta 'ble 1).
At the symptomatic stage of thiamine deficiency encephalopathy, significant region-selective in creases in densities of eH]PKll195 binding sites were seen in the brains of pyrithiamine-treated an imals ( Table 2 , Fig. 1 ). Significant increases were seen in the inferior colliculus (increased by 233%, p < 0.001), inferior olivary nucleus (increased by 154%, p < 0.001), medial geniculate nucleus of the thalamus (increased by 107%, p < 0.001) and the mammillary nucleus of the hypothalamus (in creased by 83%, p < 0.001). More modest but sta tistically significant increases were also observed in the posterior nuclei and ventroposterior nucleus of the thalamus. There were no significant alterations of eH]PK11195 binding sites in cerebral cortex, hippocampus, or caudate-putamen. Values represent mean ± SD (pmoVg of tissue) specific binding of [3H]PKII195 in presymptomatic pyrithiamine-treated and pair-fed control rats. n, number of animals per group. There were no significant differ ences between the two groups (StUdent's / test, two-tailed).
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Histopathologic studies
Neuronal cell counts were made within corre sponding brain areas of control and treated animals. Examination of histologic sections from presymp tomatic animals revealed evidence of neuronal cell loss and mild to moderate gliosis (Table 3) . Histo logic changes in the brains of symptomatic pyrithi amine-treated animals were characterized by pallor of the neuropil (Fig. 2) and by neuronal cell loss in well-demarcated areas including the medial genicu late nucleus of the thalamus, inferior olive, and in ferior colliculus (Table 3 , Fig. 3 ). In these same areas there was evidence of marked gliosis. Neither neuronal loss nor gliosis was seen in brain regions such as the caudate-putamen and frontal cortex in any of the groups (Table 3) .
DISCUSSION
Results of the present study demonstrate in creased densities of binding sites for the PTBR ligand eH]PK 11195 in the brains of rats at the symptomatic stage of thiamine deficiency encepha lopathy. Increases in binding site densities were particularly apparent in inferior colliculus, inferior olive, and thalamus, brain structures that are ulti mately the sites of selective neuronal damage in this experimental animal model of thiamine deficiency encephalopathy (Troncoso et aI., 1981; Aikawa et aI., 1984) . Densities of [3H]PKII195 binding sites in cerebral cortex, caudate-putamen, and hippocam pus, regions that are spared in thiamine deficiency, remained within normal limits.
Increased PTBRs resulting from thiamine defi ciency are most likely the consequence of glial rather than neuronal changes. Previous studies have consistently shown that these receptors are localized on nonneuronal elements, particularly glial cells (Syapin and Skolnick, 1979; McCarthy and Harden, 1981; Tardy et aI., 1981; Hertz, 1985, 1987) . Histopathologic evaluations in the present study revealed significant reductions in neuronal cell counts as early as 7 days after initia tion of pyrithiamine treatment and before the ap pearance of neurologic symptoms. Marked gliosis was not apparent until some 4-5 days later when animals showed marked neurologic impairment. Significant increases of eH]PKII 195 binding sites coincided with marked gliosis. Increased densities of PTBRs have previously been described in postmor tem brain tissue from patients with neurodegenera tive disorders such as Huntington's disease (Schoe maker et aI., 1982) and Alzheimer's disease (Owen et aI., 1983; D'Iorio et aI., 1991) . It was proposed that increases in densities of PTBRs reflected reac- Values represent mean ± SD (pmol/g of tissue) specific binding of [3H]PKI1195 in symp tomatic pyrithiamine-treated and pair-fed control rats. n, number of animals per group. a p < 0.05, bp < 0.001, significant difference between pyrithiamine-treated and pair-fed control groups by Student's t test (two-tailed).
tive gliosis accompanying neuronal loss in these conditions, and that the increases of PTBRs could provide a sensitive index of neuronal loss in these disorders (Benavides et al., 1987) .
The present findings of increased densities of eH]PK11195 binding sites are consistent with the suggestion that neuronal cell loss in thiamine deficiency is the consequence of excitotoxic damage mediated by the N-methyl-D-aspartate (NMDA) re ceptor, similar to that proposed to explain neuronal loss in cerebral ischemia. The nature of the neuro nal damage reported in pyrithiamine-induced thia mine deficiency resembles that observed in gluta mate-induced excitotoxicity (Armstrong-James et Values represent mean ± SD of neuronal cell counts made within fields of 500 x 500 f.lm in tissue sections at 250x magnification; n, number of animals per group. The degree of gliosis: + (mild), + + (moderate), + + + (marked); Med. geniculate n., medial geniculate nucleus; NS, not significant. aI., 1988) and densities of PTBRs are increased in membrane preparations from rat striata following intrastriatal administration of excitotoxic com pounds (Schoemaker et aI., 1982; Owen et aI., 1983; Benavides et aI., 1987) . In these studies increased PTBRs were found to parallel both the loss of neu ronal marker enzymes as well as the appearance of reactive gliosis (Schoemaker et aI., 1982; Benavides et aI., 1987) . Support for excitotoxic mechanisms in the pathogenesis of neuronal cell loss in thiamine deficiency encephalopathy is provided by recent re ports of selective increases of glutamate release in vulnerable brain structures of symptomatic pyrithi amine-treated rats (Hazell and Hakim, 1992) and of significant neuroprotective effects of the NMDA re ceptor antagonist MK-801 in these animals (Lang lais and Mair, 1990) .
Pyrithiamine-induced thiamine deficiency in the rat affords an appropriate experimental animal model of the WKS in humans (Heroux and Butter worth, 1992) . In both experimental thiamine defi ciency and WKS, there is a predilection for neuro nal loss in thalamic, midbrain, and brainstem struc tures (Troncoso et al., 1981; Aikawa et al., 1984; Victor et al., 1989) . Neuronal loss and concomitant gliosis are characteristic features of WKS in hu mans (Torvik et al., 1982; Harper, 1983; Victor et al., 1989) . Harper (1983) reported that in chronic lesions, parenchymal elements were lost, and reac tive changes largely restricted to astrocytes were encountered. In the study by Torvik et al. (1982) histologic changes in WKS patients included marked gliosis in medial thalamus. WKS is difficult to diagnose in patients during life, with up to 80% of cases of autopsy-proven WKS having been missed both in alcoholic patients (Harper, 1979) and in pa tients with AIDS (Butterworth et ai. , 1991) . e IC]PKll195 is a widely available ligand for use in positron emission tomography (PET). Assessment of PTBRs in brain using this PET ligand could offer a potentially useful diagnostic approach in WKS pa tients.
